RE: Balance9 Nov 2020 20:33
Testing will be here for a while for sure, but how much is GdR going to benefit from it? There are so many pharmas now which have fast tests, GDR lost their USP on “rapid testing”. Effectively, by the time they get approvals and start selling, will be almost spring, and with the vaccine staring soon, who’s willing to put money on Covid stocks still? I personally don’t see many positives, so long term not sure there is enough potential to keep people invested with big sums.
Tbh, we didn’t fair as badly as some other Covid plays, so fingers crossed a strong rebound takes this close to £1.
Good luck all